Actual Medicinal Product (AMP) Cyclizine 50mg tablets (Brown & Burk UK Ltd)

Stability Information

(Some stability information inherited from generic)

Stability
compatible_special_measures logo Lack of data and/or stability concerns exist. MCA use may be acceptable but is likely to be off-label and require mitigation measures. Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or up to 8 weeks if the MCA is airtight (sealed). Consider the risk of potency loss or dose variability and monitor for changes in efficacy or adverse effects after MCA initiation.
Notes

Protect from light. No stability data in MCAs available.

Provenance

This recommendation is based on the products Valoid 50mg tablets (ADVANZ Pharma) and Cyclizine hydrochloride 50mg Tablets (Morningside Healthcare Ltd).

Generic
Cyclizine
Formulation
Cyclizine 50mg tablets
  • Cyclizine
    • Cyclizine 50mg tablets

      • Cyclizine 50mg tablets (Brown & Burk UK Ltd)



Related Formulations (1)

compatible_special_measures logo Cyclizine 50mg tablets